3,4-dihydroxyphenylethanol has been researched along with Cardiac Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crea, R; Killeen, MJ; Linder, M; Pontoniere, P | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylethanol and Cardiac Failure
| Article | Year |
|---|---|
NF-κβ signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Biological Products; Heart Failure; Humans; Inflammation; Metabolic Diseases; NF-kappa B; Phenylethyl Alcohol; Signal Transduction | 2014 |